Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Using Vagal Nerve Stimulation In Conjunction With NRT For Smoking Cessation
NCT07487818Phase 3Recruiting
- Sponsor
- Mayo Clinic
- Start
- Jun 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
Phase 3, randomised trial in nicotine dependence (2 arms), sponsored by Mayo Clinic. Primary endpoint: Smoking Abstinence at 12 weeks. Started Jun 2026; status: recruiting.
02
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT07487818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07487818.